US5324255A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm
Assignee: Abbott Cardiovascular Systems Inc
•
Filing: 1992-07-10
•
Granted: 1994-06-28
•
Expires: 2012-07-10
Abstract
Abstract A catheter device incorporating combined ultrasound ablation and balloon dilation components. The catheter device generally comprises an elongate catheter body having proximal and distal ends and an outer surface. Disposed on the outer surface of the catheter body is a dilation balloon. At least one balloon inflation lumen fluidly connects the proximal end of the catheter body to the dilation balloon to permit injection of inflation fluid into the dilation balloon. Extending longitudinally through the catheter body is an ultrasound transmission member having a proximal end and a distal end, with the proximal end being connectable to an ultrasound transducer such that ultrasonic energy will pass through the ultrasound transmission member to the distal end thereof. In alternative embodiments of the present invention, there are provided catheter devices incorporating combined ultrasound ablation and laser ablation components as well as combined ultrasound ablation and atherectomy ablation components.
Inventors
- 👤 James D. Passafaro
- 👤 Henry Nita
- 👤 Robert J. Siegel
- 👤 Douglas H. Gesswein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:02
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/22; A61B17/22004; A61B17/22012; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B18/245; A61B17/32; A61B17/3205; A61B17/3207; A61B17/320758; A61B2017/00017; A61B2017/00022; A61B2017/00084; A61B2017/00101; A61B2017/00477; A61B2017/00831; A61B2017/0084; A61B2017/00849; A61B2017/00867; A61B2017/22014; A61B2017/22015; A61B2017/22018; A61B2017/22038; A61B2017/22039; A61B2017/22041; A61B17/320068; A61B2017/320072; A61B2017/320073; A61B2017/320088; A61B2018/00005; A61B2018/00011; A61B2018/00029; A61B2217/00; A61B2217/002; A61B2217/005; A61B2217/007; A61B90/00; A61B90/39; A61F; A61F2/00; A61F2/02; A61F2/30; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30092; A61F2210/00; A61F2210/0014; A61F2210/0023; A61F2210/0042; A61M; A61M25/00; A61M25/01; A61M2025/0183; A61M25/10; A61M25/104; A61M3/00; A61M3/02; A61M3/0279
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
121 words
A method of treating vasospasm during a transluminal balloon angioplasty procedure wherein a catheter having a dilation balloon formed thereon, and at least one lumen extending longitudinally therethrough, has been inserted into the blood vessel, and wherein vasospasm has occurred adjacent the distal end of said catheter, said method comprising the steps of: a) inserting an elongate ultrasound transmission member through the lumen of said catheter; b) connecting said elongate ultrasound transmission member to an ultrasound generating system operative to generate ultrasound energy within the frequency range of 10-1000 kHz; and, c) passing ultrasonic energy within the frequency range of 10-1000 kHz through said ultrasound transmitting member to effect treatment of said vasospasm adjacent the distal end of said catheter body.
Claim 2
Independent Claim
121 words
A method of treating vasospasm during a transluminal balloon angioplasty procedure wherein a catheter having a dilation balloon formed thereon, and at least one lumen extending longitudinally therethrough, has been inserted into the blood vessel, and wherein vasospasm has occurred adjacent the distal end of said catheter, said method comprising the steps of: a) inserting an elongate ultrasound transmission member through the lumen of said catheter; b) connecting said elongate ultrasound transmission member to an ultrasound generating system operative to generate ultrasound energy within the frequency range of 10-1000 kHz; and, c) passing ultrasonic energy within the frequency range of 10-1000 kHz through said ultrasound transmitting member to effect treatment of said vasospasm adjacent the distal end of said catheter body.
Claim 3
Dependent Claim
39 words
The method of claim 1 wherein step (c) specifically comprises: passing ultrasound having a frequency of approximately 20 Khz through said ultrasound transmission member to effect ultrasonic treatment of the vasospasm adjacent the distal end of said catheter body.
Claim 4
Dependent Claim
31 words
The method of claim 1 further comprising: (d) moving said catheter body back and forth to increase the size of the region of blood vessel to which ultrasonic treatment is delivered.
Claim 5
Dependent Claim
32 words
The method of claim 1 further comprising: (d) moving the ultrasound transmission member back and forth to increase the size of the region of blood vessel to which ultrasonic treatment is delivered.
References Cited (Backward Citations)
US3433226A
Cited
US3352303A
Cited
US3526219A
Cited
US3589363A
Cited
US3565062A
Cited
US3618594A
Cited
US3823717A
Cited
US3861391A
Cited
US3896811A
Cited
DE2453126A1
Cited
DE2349120A1
Cited
US4188952A
Cited
DE2438648A1
Cited
DE2453058A1
Cited
DE2541919A1
Cited
DE2703486A1
Cited
US4223676A
Cited
FR2424733A1
Cited
US4214586A
Cited
US4366819A
Cited
DE8119209U1
Cited
US4800876B1
Cited
US4800876A
Cited
US4431006A
Cited
US4587958A
Cited
US4665906A
Cited
US4692139A
Cited
US4979939A
Cited
US4587972A
Cited
US4960411A
Cited
US4589419A
Cited
EP0189329A2
Cited
EP0208175A2
Cited
WO1987001276A1
Cited
US4750902A
Cited
US4957111A
Cited
US4794931A
Cited
EP0234951A1
Cited
DE3707567A1
Cited
DE3707921A1
Cited
WO1987005793A1
Cited
US4821731A
Cited
US4808153A
Cited
US5058570A
Cited
US4988356A
Cited
US4967653A
Cited
US4841977A
Cited
US4799496A
Cited
GB2208138A
Cited
DE3826414A1
Cited
US4898575A
Cited
EP0315290A1
Cited
US4917097A
Cited
GB2212267A
Cited
US4870953A
Cited
WO1989005123A1
Cited
WO1989007419A1
Cited
US4844092A
Cited
DE3812836A1
Cited
US4924863A
Cited
EP0347098A2
Cited
US4920954A
Cited
US4919133A
Cited
WO1990007303A1
Cited
FR2641693A3
Cited
FR2643272A1
Cited
US5061238A
Cited
US4936281A
Cited
US5076276A
Cited
EP0443256A1
Cited
US5069664A
Cited
WO1991014401A1
Cited
EP0472368A2
Cited
US5100423A
Cited
EP1531659A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-06-27 | 1997-12-27 | 1998-06-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-06-27 | 2001-12-27 | 2002-06-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-06-27 | 2005-12-27 | 2006-06-28 | $7700.00 | Window Closed / Lapsed |